Recombinant human IL-9 (HZ-1240) stimulates dose-dependent proliferation of the MO7e (human megakaryoblastic leukemia) cell line. Cell number was quantitatively assessed by PrestoBlue® Cell Viability Reagent. MO7e cells were treated with increasing concentrations of recombinant IL-9 for 72 hours. The EC50 was determined using a 4-parameter non-linear regression model. The EC50 range is 0.15-0.85 ng/mL.